Notices. Notice of registration
376 words·~2 min read·
/register/2016/01/19/2016-00779·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: American Radiolabeled Chemicals, Inc. ACTION: Notice of registration. SUMMARY: American Radiolabeled Chemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration
(DEA)grants American Radiolabeled Chemicals, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated October 2, 2015, and published in the **Federal Register** on October 13, 2015, 80 FR 61469, American Radiolabeled Chemicals, Inc., 101 Arc Drive, Saint Louis, Missouri 63146 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of American Radiolabeled Chemicals, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Schedule Gamma Hydroxybutyric Acid
(2010)I Ibogaine
(7260)I Lysergic acid diethylamide
(7315)I Tetrahydrocannabinols
(7370)I Dimethyltryptamine
(7435)I 1-[1-(2-Thienyl)cyclohexyl]piperidine
(7470)I Dihydromorphine
(9145)I Heroin
(9200)I Normorphine
(9313)I Amphetamine
(1100)II Methamphetamine
(1105)II Amobarbital
(2125)II Phencyclidine
(7471)II Phenylacetone
(8501)II Cocaine
(9041)II Codeine
(9050)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Ecgonine
(9180)II Hydrocodone
(9193)II Meperidine
(9230)II Metazocine
(9240)II Methadone
(9250)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Morphine
(9300)II Oripavine
(9330)II Thebaine
(9333)II Oxymorphone
(9652)II Phenazocine
(9715)II Carfentanil
(9743)II Fentanyl
(9801)II The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. Dated: January 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-00779 Filed 1-15-16; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources